Democratizing Access to Broad B Cell Diversity for Rapid Monoclonal Antibody Discovery from Humans and Beyond

Vincent Pai
Associate Director, Product Management at Bruker Cellular Analysis

Democratizing Access to Broad B Cell Diversity for Rapid Monoclonal Antibody Discovery from Humans and Beyond

Click to play video

The Opto® B Discovery application on the Beacon® optofluidic system enables rapid selection of lead candidates by function-forward screening of B cells in under 1 week. This presentation will introduce Bruker Cellular Analysis’ newest antibody discovery offering for screening human memory B cells and share how customers can leverage our collective reagents, chips, and technology to rapidly discover high value monoclonal antibodies across many other species, including rat and camelids.

Speaker

Vincent Pai
Associate Director, Product Management
at Bruker Cellular Analysis

Vincent Pai is Associate Director of Product Management at Bruker Cellular Analysis. He has over 10 years of experience in cell biology, nanotechnology, and microfluidics from UC San Diego and Massachusetts General Hospital in Boston. He now leads new product development for antibody discovery applications on the Beacon® optofludic system.